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Abstract
Wearable monitoring devices are an innovative way tomeasure heart rate (HR) and heart rate variability (HRV), however, there is
still debate about the validity of these wearables. This study aimed to validate the accuracy and predictive value of the Empatica
E4 wristband against the VU University Ambulatory Monitoring System (VU-AMS) in a clinical population of traumatized
adolescents in residential care. A sample of 345 recordings of both the Empatica E4 wristband and the VU-AMS was derived
from a feasibility study that included fifteen participants. They wore both devices during two experimental testing and twelve
intervention sessions. We used correlations, cross-correlations, Mann-Whitney tests, difference factors, Bland-Altman plots, and
Limits of Agreement to evaluate differences in outcomes between devices. Significant correlations were found between Empatica
E4 and VU-AMS recordings for HR, SDNN, RMSSD, and HF recordings. There was a significant difference between the
devices for all parameters but HR, although effect sizes were small for SDNN, LF, and HF. For all parameters but RMSSD,
testing outcomes of the two devices led to the same conclusions regarding significance. The Empatica E4 wristband provides a
new opportunity to measure HRV in an unobtrusive way. Results of this study indicate the potential of the Empatica E4 as a
practical and valid tool for research on HR and HRV under non-movement conditions. While more research needs to be
conducted, this study could be considered as a first step to support the use of HRV recordings provided by wearables.
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Introduction
The past two decades have witnessed an increase in psycho-
physiological studies that incorporate heart rate (HR) and oth-
er autonomic nervous system (ANS) parameters. In particular
heart rate variability (HRV) has become the focus of psycho-
physiological research since it provides several parameters of
the parasympathetic nervous system (PNS; [1]). These param-
eters serve as an index of an individual’s physiological reac-
tivity to stress. Stress activates the sympathetic nervous sys-
tem (SNS), responsible for high arousal including the fight-or-
flight response, whereas the PNS facilitates the rest and digest
response. Both branches are essential for the immediate stress
regulatory response of the body [2]. The PNS is associated
with self-regulation aspects of cognition, affection, and social
behavior [3].
Most traditional devices that measure ANS parameters are
based on electrocardiogram (ECG) recordings, such as the
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Biopac (Biopac ECG Module, Goleta, CA) or the VU
Univers i ty Moni tor ing System (VU-AMS; Vri je
Universiteit, Amsterdam, the Netherlands). The VU-AMS is
a lightweight ECG device for ambulatory assessment that is
considered to be a ‘gold standard’ [4, 5]. Although the VU-
AMS provides excellent opportunities for ambulatory mea-
surements in real-life contexts, application of the electrodes
and setup of the device needs to be done by an expert. Simpler
and less invasive monitoring systems such as wearable wrist-
bands have been developed as a more convenient way to mea-
sure physiological parameters. Recent advances in technolo-
gy, and in particular the development of wearable monitoring
devices, have provided both researchers and lay people with a
simple, non-invasive way to measure HR. The new generation
of health monitoring devices consists of easywearable devices
that are worn as a smartwatch. Ideally, these wearables are
non-intrusive, robust to movement, and highly accurate [6].
The use of these wearable wristbands in healthcare yields high
expectations, but it is unclear whether these expectations are
warranted [7]. There are several commercially available wrist-
bands that potentially provide a range of HRV parameters,
such as the Empatica E4 wristband [7–9], the Polar watch,
[10, 11], and the Fitbit watch [12–14] among others. These
devices provide a potentially simple and promising tool for
data acquisition in both research and clinical studies [15–18],
but are artefact prone due to movement [2, 15]. Due to their
non-invasive way of monitoring, these devices are in particu-
lar suitable for vulnerable populations such as clinical
patients.
Although the reliability and validity of the VU-AMS to
obtain HRV parameters has been established [4, 5], there is
still debate on the validity of wearables as HRV monitoring
systems. The use of these wearables in real-life is in par-
ticular challenging as there is considerable amount of
movement, temperature fluctuation, and diurnal variation
in HRV that could influence the recordings and subse-
quently the utility of the data [2, 16]. Validation studies
are critical to ensure the accuracy, reliability and limita-
tions of wearables before recommending their widespread
adoption as a research tool. Studies testing the Polar V800
[10, 11] and the FitbitChargeHR™ [12] demonstrated that
HR and HRV recordings provided by wearables can be
highly comparable and show high agreement with those
of ECG systems.
Another type of wearable is the Empatica E4 wristband.
Although previous studies suggested that Empatica E4
recordingse are comparable to ECG [8, 9, 19, 20], these stud-
ies were no rigorous validation studies and had several limi-
tations. While all compared the Empatica E4 to ECG, none of
these studies used an ambulatory gold standard instruments
such as the VU-AMS as reference device [4, 5]. Second, de-
spite its potential effect on the detection of stress and emotion
[21], only Van Lier et al. [19] provided details about the
application of the Empatica E4 wristbands. They attached
the Empatica E4 on participants’ left wrists, so they were
unable to make a comparison of different measurement con-
ditions (e.g., left/right hand, dominant/non-dominant hand).
Third, most of these studies included only a few time-
domain ANS parameters such as HR and RMSSD. Only
Ollander et al. [9] included frequency-domain measurements
too. None of the previous studies included SDNN, although
SDNN is considered the best parameter for medical stratifica-
tion of cardiac risk [22]. Fourth and final, the studies of
McCarthy et al. [8], Ollander et al. [9], and Zheng and Poon
[20] were conducted with small sample sizes ranging from one
to seven participants. Only the study of Van Lier et al. [19]
was adequately powered, but their sample consisted of
University students only. In applied research, external validity
is critical. Because of their non-intrusiveness, wearables are a
promising tool for use in clinical research. Yet, it is important
to test the validity of these tools not only under ideal circum-
stances, but also in clinical settings when deployed in under
real-life routine conditions [23]. Therefore, the present study
aimed to evaluate the accuracy and predictive value of the
Empatica E4 wristband by comparing it to the VU-AMS as
reference golden standard while worn on both wrists in a
clinical population of adolescents in residential care.
Methods
Participants
Data for this study were obtained from a feasibility study
testing three game-based meditation interventions among ad-
olescents in residential care [24]. This study yielded data of
fifteen participants who wore two recording devices during
two experimental testing sessions and twelve intervention ses-
sions. During the experimental testing sessions and at the be-
ginning of each intervention sessions, participants’ baseline
HRV parameters were measured. The intervention sessions
also included at least two measurement moments of partici-
pants’ heart rate parameters during short meditation sessions.
For a detailed description of the study protocol see
Schuurmans and colleagues [25]. The sample consisted of
fifteen adolescents (nine males, six females) with a mean
age of 14.46 years (standard deviation [SD] = 2.40).
Sample size
We expected that the recordings of the two measurement de-
vices would be strongly correlated with an effect size of at
least .5 [26]. According to the sample size requirements for
estimating ICCs proposed by Bonett [27], this would require a
sample size of at least 218 cases.
190    Page 2 of 11 J Med Syst (2020) 44: 190
Although our sample did not consist of a large number of
individual participants, the study did include multiple mea-
surement days for each participant, as suggested by Bonett
[27]. One experimental testing session was conducted before
the start of the intervention and one after the intervention
ended. During these experimental testing sessions, one record-
ing was conducted. During the twelve intervention sessions, at
least two recordings were conducted. Recordings that were
retrieved during the sessions took three-to-five minutes. Data
from one participant was excluded due to a high frequency of
premature atrial complexes (PACs), a common arrhythmia
which is considered a benign phenomenon that could impact
assessments. Two participants dropped out because they re-
fused to continue with the study. In total, 356 identical seg-
ments of NN intervals were recorded, which can be consid-
ered sufficient.”
Procedure
The current validation study used different levels of validity
assessment, as suggested by Van Lier et al. [19]. They identi-
fied three levels of validity assessment: (1) signal level: the
most direct comparison that assesses the capability of a device
to generate the same raw data as the reference device; (2)
parameter level: whether a device produces physiological pa-
rameters (e.g. HR) for each individual similar to the reference
device; and (3): event level: a comparison with the reference
device on ability to significantly detect event(s) via group
means. In the current study, the validity of the Empatica E4
was assessed on the signal level with intraclass correlations
(ICCs), cross correlations (CCs) and parameter level with
Bland Altman plots. For the current study, no data were avail-
able on the event level.
Ethical review and approval were provided by the CMO
Arnhem-Nijmegen under protocol NL58674.091.16.
Adolescents were recruited within three residential youth care
institutions. All participants gave written informed assent and
their legal guardians gave written consent. Participants were
randomly assigned to one of three conditions: Muse,
Daydream, or Wild Divine Games. Although the conditions
consist of three different interventions, all make use of
meditation-based relaxation techniques and short meditation
sessions. Thus, data recordings of the three interventions were
highly comparable, making these data suitable for validation
of the Empatica E4 wristband. Participants received a 15 euro
gift check at the end of the second experimental testing
session.
Data recording
Recordings were conducted at the pre-test experimental ses-
sions (week 1), the intervention sessions (week 2–7), and at
the post-test experimental session (week 8). Participants wore
two recording devices during all sessions: the Empatica E4
wristband (Empatica Inc., Cambridge, MA, USA; [8, 9, 19])
and the VU-AMS [4, 5]. Baseline HRV parameters were ob-
tained while participants watched an aquatic video. This is a
common procedure to achieve a measurement of baseline re-
cordings to which to compare the parameters retrieved during
other conditions [28]. Participants were instructed to sit quiet-
ly and watch the aquatic video for four minutes. Halfway the
intervention there were two participants who refused to con-
tinue with the VU-AMS recordings, due to discomfort with
the electrodes that needed to be applicated and removed each
session. These participants completed the remaining sessions
without VU-AMS recordings.
Empatica E4
The Empatica E4 wristband contains four sensors: (1) an elec-
trode for Electrodermal activity (EDA), (2) 3-axis accelerome-
ter, (3) a temperature sensor, and (4) a photoplethysmography
(PPG) to measure blood volume pulse (BVP) from which it
derives HR and the inter beat interval (IBI) ([29]; see Fig. 1).
Using the Empatica Manager, data were uploaded to Empatica
Connect and raw CSV data were downloaded and analyzed
using Kubios HRV 3.0 [30]. Kubios offers five artefact correc-
tion options based on very low to very high thresholds. We
compared Empatica E4 recordings with all five Kubios artefact
correction levels to the VU-AMS recordings and without any
Kubios artefact correction. Recordings without post-hoc arte-
fact correction showed the highest correlation, so no Kubios
artefact correction was used for the analyses. This is not sur-
prising, since the Empatica E4 already uses an algorithm that
removes wrong IBIs [31].
VU-AMS
The VU-AMS is a lightweight ambulatory device that
records the electrocardiogram and changes in thorax im-
pedance from seven electrodes placed on participants’
chest and back. Five electrodes are placed on the chest
and two on the back. Participants need to partially undress
(i.e. lift up their shirt) for placement of the electrodes. The
electrodes are connected to a small device that can be
worn unobtrusively underneath participants’ clothes.
Participants are able to perform their normal daily rou-
tines with little constraint in their movements. The ECG
had a sampling rate of 1000 Hz and heart rate was obtain-
ed from the time between two adjacent R waves. For a
detailed description of the VU-AMS assessment proce-
dures see Vrije Universiteit [32]. Heart rate data were
extracted and visually inspected for artefacts with the
Data Analysis and Management Software (DAMS) pro-
gram version 4.0.
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Data analysis
Time domain analysis concerns the amount of HRVwithin the
samples. To calculate HRV parameters for time-domain anal-
ysis, 343 identical segments of NN intervals were selected
from the VU-AMS and E4 recordings. These metrics include:
– RR intervals (RR): the number of detected R waves in the
ECG.
– mean HR: average time between two heart beats.
– SDNN: the standard deviation of the NN interval, based
on normal sinus beats, thus abnormal beats (e.g. ectopic
beats that originate outside the rights artrium’s sinoatrial
node) are removed. SDNN tends to be higher when the
LF band has more power compared to the HF band [22].
– RMSSD: the root mean squared differences of successive
difference of intervals, also based on normal sinus beats.
RMSSD stands for HR beat-to-beat variance and is the
main estimation for PNS mediated changes in HRV [22].
Frequency-domain analysis allows for estimating sympa-
thetic and parasympathetic contributions of HRV. To calcu-
late HRV parameters for frequency-domain analysis, 243
identical segments of NN intervals were selected from the
VU-AMS and E4 recordings (since frequency-domain analy-
sis requires recordings of at least five minutes). Fast Fourier
transformation allows for separating HRV into components of
the power spectrum:
– Low frequency (LF) activity (0.04 to 0.15 Hz). When
measured under resting conditions, like in the present
study, it typically reflects baroreceptor activity, which
helps to maintain blood pressure [22].
– High frequency (HF) activity (0.15 to 0.40 Hz) reflects
PNS activity and is highly correlated with RMSSD [22].
The ratio between low and high frequency power (LF/
HF) is an estimation for the ratio between SNS and PNS
activity. LF/HF might provide insight in the relative in-
fluence of the SNS and PNS, but there is debate on the
relative relationship of both branches [15].
Statistical Analysis: Accuracy
Descriptive statistics (mean and SD), intraclass correlation
(ICC) and cross-correlations (CC) were calculated for all var-
iables. Cross-correlations of > .80 were considered valid [19].
Normality was assessed by Kolmogorov-Smirnov tests. None
of the variables were normally distributed (all p < .05). Mann-
Whitney tests were used to detect differences between VU-
AMS and E4 recordings. Effect size values (r) were calculated
for the significantly different outcomes to determine the effect
sizes [26]. Difference factors (DF%) were calculated to give a
difference estimation in terms of percent (XVU-AMS – XE4) /
XVU-AMS as was done by Ollander et al. [9]. Bland-Altman
plots were constructed and 95% limits of agreement (LoA),
where the true value varies, were calculated for all parameters
[33]. Bland-Altman plot analysis provides an evaluation for
the bias between mean differences of two methods, and an
estimation for an agreement interval wherein 95% of the dif-
ferences of the second method fall, compared to the first.
Statistical Analysis: Predictive Validity
To evaluate predictive validity, it was assessed to what extent
recordings provided by the Empatica E4 wristband led to the
Empatica E4 sensors  Raw data  Validated HRV parameters 




Photoplethysmography (PPG)  IBI  RMSSD 
FL
 HR  HF 
LF/HF 
3-axis accelerometer  Acceleration: range -2g, 2g   
Temperature sensor  Temperature expressed on the 
Celsius (°C) scale 
Fig. 1 Block diagram for the
Empatica E4 wristband. Note.
BVP = blood volume pulse,
EDA = electrodermal activity,
HF = high frequency, HR = heart
rate, IBI = inter beat interval,
LF = low frequency, LF/HF =
ratio between low and high
frequency, RMSSD = root mean
squared differences of successive
difference of intervals, SDNN=
standard deviation of the normal
to normal interval
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same conclusions as the VU-AMS. We conducted analyses to
assess potential differences between the three game-based in-
terventions. For each condition, Mann-Whitney tests were
conducted to test whether ANS parameters that were recorded
during meditation could be distinguished from those recorded
during rest.
All analyses were conducted four times: with Empatica E4
recordings of the device worn on participants’ left hand, worn
on participants’ right hand, worn on participants’ dominant
hand, and worn on participants’ non-dominant hand. For par-
simony, only data of the Empatica E4 recordings on partici-
pants’ left hand are reported. Differences with the E4 record-
ings on the right hand, dominant hand, or non-dominant hand




Bivariate correlations between ANS variables are presented in
Table 1. Table 2 shows descriptive statistics, difference fac-
tors, LoA and outcomes of Mann-Whitney tests for ANS pa-
rameter recordings obtained from both the VU-AMS and the
Empatica E4 during rest and mediation. Highly significant (all
p < .001) and strong ICCs were observed for HR (r = .99),
SDNN (r = .91), RMSSD (r = .89), and HF (r = .88).
Medium yet significant ICCs were observed for RR
(r = .62), LF (r = .72) and LF/HF (r =. 73). The difference
factor for HR was particularly low with 1.60%. Differences
for SDNN, LF, and HF were below 25%, those for RR,
RMSSD, and LF/HF were higher than 25%. Notably, LoA
were small for HR.
There was no difference between VU-AMS and Empatica
E4 recordings for HR. For all other parameters, significant
differences were found between the VU-AMS and Empatica
E4 recordings, although effect sizes were small for SDNN,
LF, and HF. Differences for RR, RMSSD, and LF/HF yielded
medium effect sizes. For time domain parameters, the E4 es-
timates SDNN lower and RMSSD higher than the VU-AMS.
All frequency domain parameters estimated by the E4 were
lower compared to the VU-AMS.
Figure 2A to 2D show Bland-Altman plots for combined
VU-AMS and Empatica E4 recordings on the time-domain
variables: (2A) RR; (2B) HR; (2C) SDNN; and (2D)
RMSSD. Fig. 3A to 3C show Bland-Altman plots for com-
bined recordings on the frequency-domain variables: (3A) LF;
(3B) HF; and (3C) LF/HF. The differences between and the
average of the two measures are represented on the Y-axis and
X-axis, respectively.
Predictive Value
Table 3 shows the descriptive statistics for both resting and
meditationANS parameters per game (Muse, Daydream,Wild
Divine). Separately for each game, Mann-Whitney tests were
conducted to test whether there was a difference in HR,
SDNN, RMSSD, LF, HF, and LF/HF between resting and
meditation ANS parameters. Based on the significant differ-
ences, for all parameters but RMSSD, testing outcomes of
Empatica E4 recordings led to the same conclusions as for
testing outcomes of VU-AMS recordings.
Discussion
Key findings
The present study was conducted to evaluate the accuracy and
predictive value of the Empatica E4wristband by comparing it
to the gold standard VU-AMS in a clinical population of ad-
olescents in residential care. As for accuracy, results show that
Empatica E4 recordings of HR are highly comparable to VU-
AMS recordings. For the other parameters, significant differ-
ences were found, although effect sizes were small for SDNN,
LF, and HF. The Empatica E4 has good predictive value for
all ANS parameters except for RMSSD. The statistical tests
indicated that the results of the Empatica E4 and VU-AMS
were comparable in distinguishing between resting and
meditation.
The Empatica E4 performs excellent in estimating HR.
Empatica uses two algorithms to detect heartbeats based
on the blood volume pulse. Empatica [34] states that their
goal is to only detect beats of which they are certain. As a
result of movement, pressure, or not wearing the device
tight enough, the E4 fails to detect all beats resulting in
data loss, and hence, misses the IBI on which the more
Table 1 Bivariate outcomes between ANS variables




SDNN −.11** −.58** –
RMSSD −.24** −.55** .88** –
LF .02 −.28** .57** .35** –
HF −.03 −.41** .76** .83** .00 –
LF/HF −.20** .07 −.01 −.11** −.08* −.09* –
Note. ANS = autonomic nervous system, SD = standard deviation, HR =
heart rate, SDNN= standard deviation of the NN interval, RMSSD= root
mean squared differences of successive difference of intervals, LF = low
frequency, HF = high frequency, LF/HF = ratio between low and high
frequency. * p < .05. ** p < .01
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M SD M SD DF% ICC CC LoA U p ES
RR 345.05 163.53 213.97 147.14 37.99 .62* .46 −129.88 to 399.69 29,004.00 < .001 .46
HR 84.64 11.85 83.28 11.62 1.61 .99* .60 −2.47 to 5.18 56,856.00 .115 .06
SDNN 63.24 35.16 56.94 43.08 9.96 .91* .44 −22.40 to 32.87 54,150.00 .010 .10
RMSSD 49.99 45.75 66.28 43.08 32.59 .89* .47 −58.06 to 23.24 36,230.00 < .001 .35
LF 1556.82 2427.98 1299.13 1658.38 16.55 .72* .32 −3089.23 to 3528.61 54,306.50 .009 .10
HF 2126.21 4977.59 1674.06 2733.47 21.27 .88* .33 −4998.61 to 5496.62 54,865.00 .017 .09
LF/HF 3.40 4.90 1.53 1.94 55.13 .73* .29 −5.71 to 9.62 28,618.00 < .001 .46
Note. ANS = autonomic nervous system, CC = cross-correlation, DF%= difference factor %, ES = effect size: r, HF = high frequency, HR = heart rate,
ICC = intraclass correlation, LF = low frequency, LF/HF = ratio between low and high frequency, LoA = Limits of Agreement, M =mean, RMSSD=
root mean squared differences of successive difference of intervals, SD = standard deviation, SDNN= standard deviation of the NN interval,U =Mann-
Whitney between groups effect size. * p < .01
Fig. 2 a to d: Bland-Altman Plots: Time-domain parameters. Note. HR = heart rate, RMSSD = root mean squared differences of successive difference of
intervals, SDNN = standard deviation of the NN interval
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complex calculations of HRV parameters are based. This
loss of data resulted in the relatively large difference
(37.5%) in RR detection between the Empatica E4 and
the VU-AMS. This is comparable with other studies, for
example, Van Lier et al. [19] reported an artefact percent-
age of 45% in their data.
Yet, the results indicate that in situations where participants
show minimal movement, as in our study, Empatica E4 re-
cordings of HR and SDNN are highly accurate, although the
Empatica E4 recordings are probably a slight underestimation
of the real SDNN values (given that the VU-AMS provides
higher, and presumbly more accurate, values). Surprisingly,
the RMSSD recordings, seem unreliable, since these not only
differ substantially from the VU-AMS values, but also lead to
different outcomes of statistical tests. Regarding the
frequency-domain parameters, LF and HF perform most
promising with minor differences from the VU-AMS
recordings.
Comparison to other studies
Zheng and Poon [20] and McCarthy et al. [8] did not provide
any parameters besides heart rate. Like Ollander et al. [9], we
calculated difference factors as an estimation of the difference
between recordings of the two devices. Similar to their results,
in our study difference factors for time domain parameters
were very low for HR and higher for the time domain param-
eter RMSSD. Unfortunately, they did not report SDNN.
Regarding the frequency domain parameters, our results for
LF were comparable, but our DF% was lower for HF and
higher for LF/HF. It should be noted that their sample was
very small, so no strong inferences about their findings can be
drawn.
Of all previous studies, Van Lier et al. [19] provided
the most extensive validation. Unfortunately, for time do-
main parameters, they only reported RMSSD and means
and SDs for the RR intervals. Although they reported that
Fig. 3 a to c: Bland-Altman Plots: Frequency-domain parameters. Note. HF = high frequency, LF = low frequency, LF/HF = ratio between low and high
frequency
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data of the Empatica E4 can be considered valid for HR
and RMSSD, we cannot make a comparison on SDNN,
another value besides HR that we considered as very
promising. Regarding validity on parameter level, our
findings with respect to HR show – in line with findings
of Ollander et al. [9], McCarthy et al. [8], [20], and Van
Lier et al. [19] – that the Empatica E4 suited for
estamating HR.
When we compare our results to the Polar validation stud-
ies of Giles et al. [11] and Caminal et al. [10], it can be noted
that our correlations – although significant – are lower than the
correlations of the Polar V800 and ECG recordings. These
studies did not report mean HR, but for all other parameters,
both time and frequency domain, the LoA reported in our
study were wider. However, although these studies did use
ECG to compare the Polar V800 to, these were not gold stan-
dard devices such as the VU-AMS or the Biopac.
Empatica E4 removal of artefacts
The PPG sensor of the Empatica E4 has LEDs that produce
light oriented towards the skin. The light receiver measures
the portion of the light that is reflected back. Therefore, the
sensor requires direct contact with the skin and is sensitive to
motion artefacts and incorrect placement [35, 36]. The
Empatica E4 automatically removes these artefacts from the
data, which results in shorter recordings. We found a differ-
ence score of approximately 40% in recording time between
the VU-AMS and the Empatica E4, although there was min-
imal movement during the recordings and Empatica states that
measurements in static condition could use IBI data as provid-
ed [37]. The large amount of missing IBI data suggests that the
Empatica E4 is highly sensitive to motion and motion arte-
facts, which impedes in particular its applicability for long-
term recordings in daily life and experimental conditions that
Table 3 Differences between resting and meditation ANS parameters obtained from the VU-AMS and Empatica E4 per condition
Baseline ANS ANS during meditation Testing for differences
VU-AMS Empatica E4 VU-AMS Empatica E4 VU-AMS Empatica E4
M SD M SD M SD M SD U p U p
HR
Muse 89.98 12.25 88.44 12.51 85.36 12.94 83.79 12.18 3449.00 < .001 3435.5 .002
Daydream 88.83 7.09 86.74 7.70 84.90 7.59 82.87 7.88 444.00 .012 423.50 .008
Wild Divine 77.50 9.50 75.92 9.93 75.73 7.43 75.28 8.30 595.00 .597 559.00 .995
SDNN
Muse 49.45 18.49 45.85 17.03 49.37 15.34 46.68 13.53 4794.00 .881 4358.00 .420
Daydream 43.22 15.50 41.82 15.97 56.97 16.11 52.89 16.71 325.00 < .001 412.50 .007
Wild Divine 104.94 43.64 95.09 49.34 119.37 38.34 99.23 31.42 488.00 .086 445.50 .155
RMSSD
Muse* 29.54 15.97 54.09 23.82 37.27 19.19 54.69 22.74 3652.00 .001 4555.50 .756
Daydream* 27.47 13.06 51.03 21.10 37.61 14.41 59.15 18.42 368.00 .001 506.00 .089
Wild Divine 110.55 74.30 121.88 84.30 109.25 62.25 105.71 56.59 638.00 .954 524.00 .662
LF
Muse 915.34 889.27 802.51 766.86 821.87 684.10 760.74 722.40 1688.00 .986 4615.00 .838
Daydream 532.34 394.17 633.43 609.70 1254.81 1019.76 1392.24 1295.98 283.00 < .001 369.00 .001
Wild Divine 1695.82 889.49 1778.18 1124.74 5840.89 5071.62 4051.13 2945.14 506.00 < .001 253.00 < .001
HF
Muse 345.65 405.47 663.57 613.32 581.32 599.53 919.47 867.93 1175.00 .005 3672.50 .010
Daydream 371.61 373.80 694.93 645.88 755.15 754.40 1172.21 980.27 367.00 .004 444.00 .016
Wild Divine 8259.74 9113.69 5093.93 5191.74 7051.98 7527.71 4792.88 4401.17 357.00 .569 547.00 .877
LF/HF
Muse 5.63 7.28 1.74 1.82 3.08 4.03 1.42 1.71 1184.00 .006 3906.50 .049
Daydream 2.10 1.56 1.11 0.68 2.40 1.80 1.42 0.96 530.00 .328 561.00 .272
Wild Divine 0.69 0.68 0.60 0.51 3.75 4.30 2.68 3.69 234.00 .008 354.00 .008
Note. ANS autonomic nervous system, SD standard deviation, HR heart rate, SDNN standard deviation of the NN interval, RMSSD root mean squared
differences of successive difference of intervals, LF low frequency, HF high frequency, LF/HF ratio between low and high frequency. * = different
testing outcomes based on VU-AMS and Empatica E4 recordings
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include exercise or movement. Artefacts in real-life situations
are expected to have a significant influence on parameter es-
timation, which warrants further research on wearable, wrist-
worn devices.
Strengths and limitations
Although four previous studies have provided a preliminary
examination of the Empatica E4, this is, to our knowledge, the
first study examining the validity of the Empatica E4 wrist-
band while worn on both wrists and compared with a gold
standard ECG device. The study was conducted with fifteen
participants, but due to the repeated recording moment, our
sample for time-domain analysis included 345 recording seg-
ments, which can be considered a valid sample size to validate
ANS parameters [19]. Moreover, this study was conducted in
a clinical population of adolescents in residential care and thus
requires minimal translation to be relevant for clinical care.
While posing substantial scientific challenges, research in
clinical contexts is critical for practical innovation. We need
to be aware of both the practical advantages and limitations of
wearable HRV monitoring devices to decide whether these
devices can be used in clinical care. For example, it should
be noted that halfway the study, two participants refused to
continue with the VU-AMS recordings due to discomfort,
while they were willing to complete the remaining sessions
wearing only the Empatica E4 wristbands. This illustrates the
major practical advantage of wearable monitoring devices:
wristbands do not require the application of electrodes and
are non-intrusive, comfortable, and easy to wear.
To conduct the analyses for this study, we used data from a
feasibility study that focused on measuring HR and HRV.
While the Empatica E4 also measures EDA, XYZ raw accel-
eration, and skin temperature, the available data did not in-
clude these parameters. In particular EDA is a useful measure
of sympathetic activation [38]. We have to refrain from draw-
ing strong conclusions regarding the validity of the Empatica
E4 only based on its HR and HRV data. Future validation
studies should include assessments of the other parameters
provided by the Empatica E4, and possibly combine informa-
tion from different parameters to see whether combinations
could be even more informative. Also, our recordings were
made under static conditions while participants were at rest.
While informative as a first step toward validation of the
Empatica E4, future research that include gold a standard ref-
erence device could focus on its ability to distinguish between
states of stress and states of rest, and its recording quality
when participants do not sit still. As our measurements did
not include a stressor that was expected to prompt physiolog-
ical changes, we were unable to assess validity on the event
level.
In this validation study we used Kubios to process the
Empatica E4 recordings, as recommended by Empatica [39].
For the VU-AMS recordings, we used the DAMS program
that was developed to analyze VU-AMS recordings (Vrije
[32]). The reported differences between the Empatica E4
and VU-AMS recordings may – partly – be caused by soft-
ware differences in processing and calculating HR and HRV
parameters. In particular for frequency domain parameters, the
use of different mathematical methods could lead to different
results [40]. It is noteworthy that in this study, the Empatica
E4 performed worst on the frequency domain parameters.
Although it is possible to analyze VU-AMS recordings in
Kubios, we decided not to since this would deviate from the
gold standard method that we wanted to compare the
Empatica E4 to. Agreement between the two devices might
have been higher when VU-AMS recordings were also ana-
lyzed with Kubios.
Conclusions
The development of wearable health technology provides new
opportunities to measure HRV with easy-to-use devices such
as the Empatica E4 wristband in clinical practice. Findings of
the present study indicate that the Empatica E4 is practical and
feasible for recording a limited set of ANS parameters. The
strong correlations and agreement found between Empatica
E4 and VU-AMS recordings for mean HR and SDNN suggest
its potential as a valid tool for research on HR and HRV while
people are at rest. While more research needs to be conducted,
this study could be considered as a first step to support the use
of HRV recordings provided by wearables.
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